BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $7,773,000 | -15.2% | 100,252 | -6.1% | 0.04% | -8.7% |
Q4 2021 | $9,165,000 | +8.6% | 106,756 | +1.7% | 0.05% | -2.1% |
Q3 2021 | $8,443,000 | -7.6% | 104,961 | -7.5% | 0.05% | -4.1% |
Q2 2021 | $9,133,000 | -4.7% | 113,455 | -0.1% | 0.05% | -12.5% |
Q1 2021 | $9,579,000 | -71.3% | 113,574 | -72.7% | 0.06% | -72.4% |
Q4 2020 | $33,368,000 | -13.4% | 415,873 | -13.2% | 0.20% | -18.5% |
Q3 2020 | $38,538,000 | +39.1% | 479,178 | +48.9% | 0.25% | +33.9% |
Q2 2020 | $27,712,000 | +6.1% | 321,849 | +0.1% | 0.19% | -12.7% |
Q1 2020 | $26,112,000 | +19.6% | 321,604 | +23.1% | 0.21% | +43.9% |
Q4 2019 | $21,840,000 | +9.5% | 261,192 | +14.5% | 0.15% | -5.1% |
Q3 2019 | $19,947,000 | +5.8% | 228,034 | -1.0% | 0.16% | +4.7% |
Q2 2019 | $18,857,000 | +0.9% | 230,241 | +0.2% | 0.15% | +2.1% |
Q1 2019 | $18,683,000 | +7.8% | 229,763 | -12.8% | 0.15% | -0.7% |
Q4 2018 | $17,337,000 | -21.8% | 263,403 | -8.4% | 0.15% | -8.1% |
Q3 2018 | $22,166,000 | +14.2% | 287,551 | +9.4% | 0.16% | +12.7% |
Q2 2018 | $19,414,000 | -33.1% | 262,921 | -41.0% | 0.14% | -32.1% |
Q1 2018 | $29,000,000 | -30.9% | 445,891 | -31.3% | 0.21% | -29.4% |
Q4 2017 | $41,960,000 | -26.9% | 649,133 | -29.0% | 0.30% | -18.9% |
Q3 2017 | $57,396,000 | +96.5% | 914,672 | +89.5% | 0.36% | +35.2% |
Q2 2017 | $29,216,000 | +19.5% | 482,579 | +2.3% | 0.27% | +16.4% |
Q1 2017 | $24,458,000 | +192.6% | 471,627 | +150.2% | 0.23% | +193.7% |
Q4 2016 | $8,359,000 | -72.9% | 188,518 | -70.9% | 0.08% | -72.8% |
Q3 2016 | $30,868,000 | -18.7% | 648,491 | -22.8% | 0.29% | -19.2% |
Q2 2016 | $37,984,000 | -19.6% | 839,991 | -27.0% | 0.36% | -20.9% |
Q1 2016 | $47,267,000 | – | 1,150,618 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
13D Management LLC | 194,807 | $11,794,000 | 4.18% |
Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |